Principaux concurrents
Rendement du dividende (N) Rendement du dividende (N+1) PER (N) Price to Book (N) VE / CA (N) VE / EBITDA (N) VE / EBIT (N) Capi.($)
0,04 %0,09 %33.11x6.29x8.21x25.31x25.8x 56,19 Md
1,54 %1,75 %20.62x3.99x6.35x13.89x16.12x 54,83 Md
-.--%-.--%-18.25x1.12x4.33x-7.59x-6.4x 23,04 Md
-.--%-.--%-41x52.93x13.02x-38.35x-42.08x 22,7 Md
-.--%-.--%25.46x2.49x4.98x13.19x15.76x 20,23 Md
-.--%-.--%24.92x2.83x4.83x15.71x17.71x 17,83 Md
-.--%-.--%-786.44x19.37x37.38x-4208.26x-528.82x 15,65 Md
0,08 %0,12 %45.88x11.77x18.59x47.88x43.92x 15,24 Md
-.--%-.--%17.56x5x5.09x11.87x13.13x 14,03 Md
-.--%-.--%-26.55x28.43x25.04x-31.62x-25.46x 12,05 Md
-.--%0,02 %-5268.97x8.22x14.49x96.62x430.22x 11,58 Md
-.--%-.--%-12.61x-87.59x91.78x-14.31x-13.9x 10,95 Md
-.--%-.--%-11.3x38.93x3025.58x-12.92x-11.23x 10,45 Md
-.--%-.--%-32.55x8.95x - -30.12x-29.14x 8,8 Md
-.--%-.--%12.21x6x7.91x12.68x11.75x 8,72 Md
0,38 %0,44 %19.79x5.6x - - - 8,05 Md
Moyenne 0,13 % 0,15 % -374,88x 7,14x 233,40x -273,74x -5,51x 19,4 Md
Moyenne pondérée par Capi. 0,29 % 0,34 % -226,81x 8,10x 120,98x -208,40x -4,32x
Médicaments bio-thérapeutiques
🔇